http://www.bms.com
Bristol-Myers Squibb Company Company Intro
Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Industry
Healthcare
Bristol-Myers Squibb Company Headquaters
430 East 29th Street
New York,10016
United States
Bristol-Myers Squibb Company Share price
23 Oct 2020 01:14 GMT
$59.98
-0.05 (-0.08 %)
Bristol-Myers Squibb Company Market cap
$136.949 B
WMC RANKING
2020
Bristol-Myers Squibb Company # 10
Drug Manufacturers—GeneralLatest Bristol-Myers Squibb Company News
22 Oct 2020
SHAREHOLDER ALERT: Monteverde & Associates Continues ...
(NASDAQ:MYOK) relating to the merger agreement with Bristol-Myers Squibb Company. Under the terms of the agreement, MyoKardia shareholders shall be ...
22 Oct 2020
Inflammatory Bowel Disease Market Is Thriving Worldwide ...
Inflammatory Bowel Disease Market Is Thriving Worldwide | Bristol-Myers Squibb Company, Baxter International, Johnson & Johnson, Sanofi-Aventis, Abbott ...
22 Oct 2020
Emotional Agility: Adapting Your Leadership Strategy in ...
Senior VP of Global Regulatory Strategy and Policy, Bristol Myers Squibb (BMS). NOTE: The company dropped the hyphen in their name officially
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Bristol-Myers Squibb Company | 43.12 | 25.52 | 89.82 | 0 | 0 | 0 | 49.53 |
| Johnson & Johnson | 100 | 100 | 32.98 | 100 | 0 | 0 | 100 |
| Merck & Co., Inc. | 58.37 | 20.68 | 42.11 | 0 | 0 | 0 | 26.96 |
| AbbVie Inc. | 42.12 | 7.16 | 100 | 0 | 0 | 0 | 46.03 |
| AstraZeneca PLC | 31.78 | 23.63 | 12.28 | 2 | 0 | 0 | 16.11 |
Bristol-Myers Squibb Company Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Bristol-Myers Squibb Company | $34,862,000 | $20,226,000 | $-563,000 | $135.191B | 10 |
| Johnson & Johnson | $80,856,000 | $33,169,000 | $16,986,000 | $378.942B | 1 |
| Merck & Co., Inc. | $47,194,000 | $20,494,000 | $10,479,000 | $197.458B | 2 |
| AbbVie Inc. | $34,057,000 | $12,564,000 | $8,394,000 | $146.287B | 3 |
| AstraZeneca PLC | $25,699,000 | $17,950,000 | $2,148,000 | $105.85B | 4 |